Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05949515 · ClinicalTrials.gov registry record
Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility
A clinical trial of Acute ST Segment Elevation Myocardial Infarction, sponsored by Cardiovascular Research Foundation, New York.
- Completed
- Registry status
- 403
- Enrollment target
- 8
- Study locations
NCT05949515: Completed study of Acute ST Segment Elevation Myocardial Infarction, sponsored by Cardiovascular Research Foundation, New York.
NCT05949515 is a study of Acute ST Segment Elevation Myocardial Infarction that has completed, run by Cardiovascular Research Foundation, New York. The registered enrollment target is 403 participants. The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05949515, a study of Acute ST Segment Elevation Myocardial Infarction, has completed, sponsored by Cardiovascular Research Foundation, New York.
- COMPLETED
- Registry status
- 403 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).
Primary Outcome
Between group comparison
Conditions Studied
Study Locations (8)
Florida
- Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute - Miami
- NCH Healthcare System - Naples
Ohio
- OhioHealth Research Institute - Columbus
- Avita Health - Galion
Michigan
- Oakwood Healthcare, Inc - Dearborn
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
New York
- Northwell Health, Inc - Great Neck
West Virginia
- St. Mary's Medical Center - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2023-07-31 |
| Est. Completion | 2024-03-31 |
What the finished NCT05949515 record still lists
NCT05949515 is an observational study that tracks outcomes without assigning an intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Acute ST Segment Elevation Myocardial Infarction appearing as the primary indexed condition, and to 0 interventions.
NCT05949515 lists 8 locations in 6 states (Florida, Ohio, Michigan).
Frequently Asked Questions
What is clinical trial NCT05949515 about?
NCT05949515 is a clinical study titled "Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility". The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).
What is the current status of trial NCT05949515?
This trial is currently completed. The enrollment target is 403 participants. The study started on 2023-07-31. Estimated completion is 2024-03-31.
What conditions does trial NCT05949515 study?
This clinical trial studies the following conditions: Acute ST Segment Elevation Myocardial Infarction.
Who is sponsoring clinical trial NCT05949515?
This trial is sponsored by Cardiovascular Research Foundation, New York, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05949515 being conducted?
This trial has 8 study locations across Florida, Michigan, Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
- NCT06244771 · 403 participants · Phase 1
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI